AcquisitionOther
ALIMERA SCIENCES INC acquired Alimera
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
ALIMERA SCIENCES INC -> Alimera · $5.50
Nikhil Lalwani, President and CEO of ANI, stated, "We believe this is a transformational acquisition for ANI, and one that aligns with our strategy to expand our Rare Disease business and deliver on our purpose of ‘Serving Patients, Improving Lives'.
Open source record (SEC) ↗